Results 101 to 110 of about 1,621,073 (318)
BLOOD VOLUME IN CLINICAL SHOCK. I. MIXING TIME AND DISAPPEARANCE RATE OF T-1824 IN NORMAL SUBJECTS AND IN PATIENTS IN SHOCK; DETERMINATION OF PLASMA VOLUME IN MAN FROM 10-MINUTE SAMPLE12 [PDF]
Robert P. Noble+3 more
openalex +1 more source
Objective Our objective was to examine the relationship between colchicine plasma concentrations and clinical and demographic factors and to determine the relationship between colchicine concentrations and colchicine efficacy and colchicine‐specific adverse events.
Lisa K. Stamp+8 more
wiley +1 more source
Editorial: Insights in clinical and translational physiology: 2022
Yu-Sok Kim+5 more
doaj +1 more source
Extracellular vesicles (EVs) play a dual role in diagnostics and therapeutics, offering innovative solutions for treating cancer, cardiovascular, neurodegenerative, and orthopedic diseases. This review highlights EVs’ potential to revolutionize personalized medicine through specific applications in disease detection and treatment.
Farbod Ebrahimi+4 more
wiley +1 more source
A Study of Liver Function and Plasma Volume in Chronic Rheumatism by Means of Phenol-Tetrabrom-Phthalein Sodium Sulphonate [PDF]
Guy Robinson
openalex +1 more source
Using supramolecular monomers, various hydrogel culture systems were formulated to culture protoplasts; including 2D, 2.5D, and 3D hydrogels. Depending on the culture platform, bioactive functionalization led to protoplast enlargement (2D and 2.5D) or plasmolysis (3D). This work shows the potential to modularly engineer synthetic platforms for cellular
Maritza M. Rovers+3 more
wiley +1 more source
Influence of Hemofiltration on Intradialytic Plasma Volume Decrease
Background/Aims: Compared with hemodialysis (HD), hemodiafiltration (HDF) reduces the frequency of episodes of intradialytic hypotension. Intradialytic plasma volume decrease (IPVD) induced by ultrafiltration is a leading cause of the episodes, and ...
Masayuki Tanemoto+4 more
doaj +1 more source
The prodrug strategy used in this study offers new promise for cancer metabolism‐based therapies. JHU083, a prodrug that, when cleaved by protease in the tumor microenvironment, yields the glutamine antagonist DON. JHU083 inhibits tumor growth by targeting glutamine‐addicted cancer cells and suppressing glutamine‐dependent M2 macrophages, leading to a ...
Tianhe Li+10 more
wiley +1 more source
THE DETERMINATION OF PLASMA VOLUME IN MAN WITH RADIOACTIVE CHROMIC CHLORIDE 1 [PDF]
Heddy Frank, Seymour J. Gray
openalex +1 more source
Plasma volume in macroglobulinaemia. [PDF]
I. S. Menzies, C. Hirson
openaire +3 more sources